share_log

Maxim Group Downgrades Zivo Bioscience to Hold

Benzinga ·  Jun 4, 2024 23:28

Maxim Group analyst Anthony Vendetti downgrades Zivo Bioscience (OTC:ZIVO) from Buy to Hold.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment